Literature DB >> 900222

Treatment of total hyphemas with urokinase.

D M Leet.   

Abstract

Total hyphemas were created by aspirating the aqueous humor from the anterior chambers of rabbit eyes and then injecting human blood. Thirty-six of these eyes were then treated with urokinase. A control group of 26 eyes was treated with normal saline. Nine eyes with total hyphemas were left untreated. The untreated eyes had uniformly bad results with prolonged elevation of intraocular pressures, marked ciliary injection, and corneal vascularization. The normal saline control eyes cleared faster than the untreated eyes, probably because of the mechanical dissolution of the clot with irrigation or injection. However, these control eyes showed significantly poorer results than the enzyme-treated eyes. The eyes treated with urokinase, whether injected or irrigated, had a marked increase in the rate of absorption of clot and less fibrin formation in the anterior chamber. Intraocular pressures returned to normal much sooner in these eyes than in untreated eyes, and most corneas cleared completely.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 900222     DOI: 10.1016/0002-9394(77)90329-4

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Randomised controlled trial of intrapleural streptokinase in community acquired pleural infection.

Authors:  R J Davies; Z C Traill; F V Gleeson
Journal:  Thorax       Date:  1997-05       Impact factor: 9.139

2.  Anterior segment consequences of blunt ocular injury.

Authors:  Y M Canavan; D B Archer
Journal:  Br J Ophthalmol       Date:  1982-09       Impact factor: 4.638

3.  A 10-year survey of eye injuries in Northern Ireland, 1967-76.

Authors:  Y M Canavan; M J O'Flaherty; D B Archer; J H Elwood
Journal:  Br J Ophthalmol       Date:  1980-08       Impact factor: 4.638

4.  Eight-ball hyphema after laser iridotomy in a patient with undiagnosed hypocellular myelodysplastic syndrome.

Authors:  Sira Arunmongkol; Yanin Suwan; Wasu Supakontanasan; Suthaphat Nilphatanakorn; Chaiwat Teekhasaenee
Journal:  Int Med Case Rep J       Date:  2018-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.